Document is current
Any future updates will be listed below
-
Authors
Cance, J. D. https://orcid.org/0000-0002-2797-0037
Adams, E. T.
D’Amico, E. J.
Palimaru, A.
Fernandes, C. S. F.
Fiellin, L. E.
Bonar, E. E.
Walton, M. A.
Komro, K. A.
Knight, D.
Knight, K.
Rao, V.
Youn, S.
Saavedra, L.
Ridenour, T. A.
Deeds, B.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (U24 DA050182)
National Institute on Drug Abuse (U24 DA050182)
National Institute on Drug Abuse (U24 DA050182)
National Institute on Drug Abuse (U24 DA050182)
National Institute on Drug Abuse (UG3/UH3 DA050235)
National Institute on Drug Abuse (UG3/UH3 DA050235)
National Institute on Drug Abuse (UG3/UH3 DA050251)
National Institute on Drug Abuse (UG3/UH3 DA050251)
National Institute on Drug Abuse (UG3/UH3 DA050173)
National Institute on Drug Abuse (UG3/UH3 DA050173)
National Institute on Drug Abuse (UG3/UH3 DA050234)
National Institute on Drug Abuse (UG3/UH3 DA050250)
National Institute on Drug Abuse (UG3/UH3 DA050250)
National Institute on Drug Abuse (UG3/UH3 DA050252)
National Institute on Drug Abuse (UG3/UH3 DA050252)
- License Information
-
More Information
Article History
Accepted: 11 May 2023
First Online: 1 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Fiellin holds equity with Playbl, Inc., a small commercial venture that focuses on the distribution of evidence-based video games for risk reduction and prevention in youth and young adults. This relationship is extensively managed by Dr. Fiellin and her academic institution.
